Dr. Miriam Merad, M.D., Ph.D., is the Mount Sinai Endowed professor in Cancer Immunology and the Director of the Precision Immunology Institute at Mount Sinai School of Medicine in New York. Dr. Merad also co-leads the Cancer Immunology program at The Mount Sinai Tisch Cancer Institute and is the Director of the Mount Sinai Human Immune Monitoring Center (HIMC). Dr. Merad’s laboratory made seminal discoveries that contribute to our understanding of the development and functional identity of tissue resident dendritic cells and macrophages during homeostasis, and examined how these regulations are changed in cancer and inflammatory diseases. She is a member of the American Society of Clinical Investigation, a recipient of the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, the President-elect of the International Union of Immunological Societies, and was elected in 2020 to the National Academy of Sciences. Read more about Dr. Merad here (https://icahn.mssm.edu/profiles/miriam-merad).